PNT
Morgan Stanley’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-128,244
| Closed | -$855K | – | 7940 |
|
|
2023
Q3 | $855K | Sell |
128,244
-75,466
| -37% | -$503K | ﹤0.01% | 4891 |
|
|
2023
Q2 | $1.85M | Buy |
203,710
+50,094
| +33% | +$454K | ﹤0.01% | 4481 |
|
|
2023
Q1 | $1.12M | Buy |
153,616
+107,946
| +236% | +$785K | ﹤0.01% | 4796 |
|
|
2022
Q4 | $333K | Buy |
45,670
+25,747
| +129% | +$188K | ﹤0.01% | 5440 |
|
|
2022
Q3 | $155K | Sell |
19,923
-56,754
| -74% | -$442K | ﹤0.01% | 5853 |
|
|
2022
Q2 | $521K | Buy |
76,677
+61,942
| +420% | +$421K | ﹤0.01% | 5398 |
|
|
2022
Q1 | $117K | Buy |
14,735
+8,830
| +150% | +$70.1K | ﹤0.01% | 6226 |
|
|
2021
Q4 | $33K | Buy |
5,905
+2,420
| +69% | +$13.5K | ﹤0.01% | 7003 |
|
|
2021
Q3 | $27K | Buy |
+3,485
| New | +$27K | ﹤0.01% | 6982 |
|